| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.04 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.04 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.12 | 0.05 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.05 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |